
    
      A randomised, double-blind, placebo controlled, dose ascending, parallel group study to
      evaluate the safety, tolerability, steady state pharmacokinetics and pharmacodynamics of
      SB-656933-AAA following repeated doses in healthy adult subjects. The pharmacokinetic
      interaction between repeated doses of SB-656933-AAA and single dose of simvastatin will also
      be assessed.
    
  